[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2019 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
29-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- 1.57%
YoY- 29.96%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 604,088 634,852 576,462 584,942 591,704 601,544 498,722 13.64%
PBT 74,236 70,908 70,809 75,826 74,204 75,144 59,666 15.69%
Tax -17,656 -16,664 -15,536 -18,173 -17,442 -17,284 -12,025 29.21%
NP 56,580 54,244 55,273 57,653 56,762 57,860 47,641 12.15%
-
NP to SH 56,580 54,244 55,273 57,653 56,762 57,860 47,641 12.15%
-
Tax Rate 23.78% 23.50% 21.94% 23.97% 23.51% 23.00% 20.15% -
Total Cost 547,508 580,608 521,189 527,289 534,942 543,684 451,081 13.79%
-
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div 6,843 - 40,937 8,994 13,237 - 36,403 -67.21%
Div Payout % 12.10% - 74.06% 15.60% 23.32% - 76.41% -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 581,725 540,662 525,364 505,919 503,029 496,410 483,173 13.18%
NOSH 684,383 684,383 684,383 680,106 661,881 661,881 661,881 2.25%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 9.37% 8.54% 9.59% 9.86% 9.59% 9.62% 9.55% -
ROE 9.73% 10.03% 10.52% 11.40% 11.28% 11.66% 9.86% -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 88.27 92.76 84.49 86.71 89.40 90.88 75.35 11.13%
EPS 8.26 7.92 8.25 8.65 8.52 8.76 7.26 8.99%
DPS 1.00 0.00 6.00 1.33 2.00 0.00 5.50 -67.93%
NAPS 0.85 0.79 0.77 0.75 0.76 0.75 0.73 10.68%
Adjusted Per Share Value based on latest NOSH - 680,106
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 62.80 66.00 59.93 60.81 61.51 62.53 51.85 13.63%
EPS 5.88 5.64 5.75 5.99 5.90 6.01 4.95 12.17%
DPS 0.71 0.00 4.26 0.93 1.38 0.00 3.78 -67.23%
NAPS 0.6047 0.5621 0.5461 0.5259 0.5229 0.5161 0.5023 13.17%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 1.62 1.39 1.42 1.40 1.37 1.28 0.95 -
P/RPS 1.84 1.50 1.68 1.61 1.53 1.41 1.26 28.74%
P/EPS 19.60 17.54 17.53 16.38 15.98 14.64 13.20 30.18%
EY 5.10 5.70 5.70 6.10 6.26 6.83 7.58 -23.23%
DY 0.62 0.00 4.23 0.95 1.46 0.00 5.79 -77.48%
P/NAPS 1.91 1.76 1.84 1.87 1.80 1.71 1.30 29.26%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 13/08/20 18/05/20 13/02/20 29/11/19 30/08/19 21/05/19 18/02/19 -
Price 3.15 1.72 1.64 1.39 1.41 1.36 1.03 -
P/RPS 3.57 1.85 1.94 1.60 1.58 1.50 1.37 89.47%
P/EPS 38.10 21.70 20.24 16.26 16.44 15.56 14.31 92.21%
EY 2.62 4.61 4.94 6.15 6.08 6.43 6.99 -48.04%
DY 0.32 0.00 3.66 0.96 1.42 0.00 5.34 -84.71%
P/NAPS 3.71 2.18 2.13 1.85 1.86 1.81 1.41 90.70%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment